FIGURE 3.

Individual participant dynamics of T‐HBsAg and M‐HBsAg isoforms and alanine aminotransferase (ALT) in the 4 REP 301 participants with residual qHBsAg present at the end of REP 2139‐Ca monotherapy. The qHBsAg and alanine aminotransferase (ALT) data were previously published^{[ 33 ]}